Corrigendum to: “miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression” [Biomedicine & Pharmacotherapy (71), (2015) 112–118]

Corrigendum to: “miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression” [Biomedicine & Pharmacotherapy (71), (2015) 112–118]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2016-12, Vol.84, p.1440-1441
Hauptverfasser: Wei, Junhua, Qi, Xuchen, Zhan, Qitao, Zhou, Daoyang, Yan, Qingfeng, Wang, Yirong, Mo, Lianjie, Wan, Yingfeng, Xie, Dajiang, Xie, Jixi, Yang, Shuxu
Format: Artikel
Sprache:eng
Schlagworte:
Internal Medicine
Medical Education
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1441
container_issue
container_start_page 1440
container_title Biomedicine & pharmacotherapy
container_volume 84
creator Wei, Junhua
Qi, Xuchen
Zhan, Qitao
Zhou, Daoyang
Yan, Qingfeng
Wang, Yirong
Mo, Lianjie
Wan, Yingfeng
Xie, Dajiang
Xie, Jixi
Yang, Shuxu
description
doi_str_mv 10.1016/j.biopha.2016.09.109
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835517525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0753332216318029</els_id><sourcerecordid>1835517525</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2118-4eb3f67b592d97ac9f4c55caa8ddc15cf288e13716d843a529e56be4830fd64c3</originalsourceid><addsrcrecordid>eNqFUk2P0zAQjRCI7S78A4R8Ql2JFH_Eib0HJKhgWakSaIETQpbjTFqXJC52Um059T9whb_BD-ovwVEXDlw4jWb05o3ee5MkjwieEUzyZ-tZad1mpWc0djMs41TeSSZEcpzmGBd3kwkuOEsZo_QkOQ1hjTHmORP3kxNaFLnkQkySX3PnvV1CVw0t6t0FOux_tPY6pVijFiqrewioh9Z9c41rbQWph2BDrzsDyHZo2VhXNjr0rtXIQNMEtLUadbDUvd1Cs0MelkMTm26JFtdXlwTBzSZyBOu6w_4n-vTSuvGQsR2gJ-jdSvtWG9evwOvNDk0Lcv4UTaNGfo4IoYf9d0LE5wfJvVo3AR7e1rPk4-tXH-Zv0sXby6v5i0VqaISlGZSszouSS1rJQhtZZ4Zzo7WoKkO4qakQQFhB8kpkTHMqgeclZILhusozw86S6ZF3493XAUKvWhtGmboDNwRFBOOcFJzyCM2OUONdCB5qtfG21X6nCFZjYmqtjompMTGFZZzKuPb49sJQRh_-Lv2JKAKeHwEQdW4teBWMhWh_ZT2YXlXO_u_CvwSmsZ01uvkCOwhrN_gueqiIClRh9X78mvFpSM6IwFSy37-2wQI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835517525</pqid></control><display><type>article</type><title>Corrigendum to: “miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression” [Biomedicine &amp; Pharmacotherapy (71), (2015) 112–118]</title><source>Elsevier ScienceDirect Journals</source><creator>Wei, Junhua ; Qi, Xuchen ; Zhan, Qitao ; Zhou, Daoyang ; Yan, Qingfeng ; Wang, Yirong ; Mo, Lianjie ; Wan, Yingfeng ; Xie, Dajiang ; Xie, Jixi ; Yang, Shuxu</creator><creatorcontrib>Wei, Junhua ; Qi, Xuchen ; Zhan, Qitao ; Zhou, Daoyang ; Yan, Qingfeng ; Wang, Yirong ; Mo, Lianjie ; Wan, Yingfeng ; Xie, Dajiang ; Xie, Jixi ; Yang, Shuxu</creatorcontrib><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2016.09.109</identifier><identifier>PMID: 27769588</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Internal Medicine ; Medical Education</subject><ispartof>Biomedicine &amp; pharmacotherapy, 2016-12, Vol.84, p.1440-1441</ispartof><rights>2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0753332216318029$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27769588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wei, Junhua</creatorcontrib><creatorcontrib>Qi, Xuchen</creatorcontrib><creatorcontrib>Zhan, Qitao</creatorcontrib><creatorcontrib>Zhou, Daoyang</creatorcontrib><creatorcontrib>Yan, Qingfeng</creatorcontrib><creatorcontrib>Wang, Yirong</creatorcontrib><creatorcontrib>Mo, Lianjie</creatorcontrib><creatorcontrib>Wan, Yingfeng</creatorcontrib><creatorcontrib>Xie, Dajiang</creatorcontrib><creatorcontrib>Xie, Jixi</creatorcontrib><creatorcontrib>Yang, Shuxu</creatorcontrib><title>Corrigendum to: “miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression” [Biomedicine &amp; Pharmacotherapy (71), (2015) 112–118]</title><title>Biomedicine &amp; pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><subject>Internal Medicine</subject><subject>Medical Education</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqFUk2P0zAQjRCI7S78A4R8Ql2JFH_Eib0HJKhgWakSaIETQpbjTFqXJC52Um059T9whb_BD-ovwVEXDlw4jWb05o3ee5MkjwieEUzyZ-tZad1mpWc0djMs41TeSSZEcpzmGBd3kwkuOEsZo_QkOQ1hjTHmORP3kxNaFLnkQkySX3PnvV1CVw0t6t0FOux_tPY6pVijFiqrewioh9Z9c41rbQWph2BDrzsDyHZo2VhXNjr0rtXIQNMEtLUadbDUvd1Cs0MelkMTm26JFtdXlwTBzSZyBOu6w_4n-vTSuvGQsR2gJ-jdSvtWG9evwOvNDk0Lcv4UTaNGfo4IoYf9d0LE5wfJvVo3AR7e1rPk4-tXH-Zv0sXby6v5i0VqaISlGZSszouSS1rJQhtZZ4Zzo7WoKkO4qakQQFhB8kpkTHMqgeclZILhusozw86S6ZF3493XAUKvWhtGmboDNwRFBOOcFJzyCM2OUONdCB5qtfG21X6nCFZjYmqtjompMTGFZZzKuPb49sJQRh_-Lv2JKAKeHwEQdW4teBWMhWh_ZT2YXlXO_u_CvwSmsZ01uvkCOwhrN_gueqiIClRh9X78mvFpSM6IwFSy37-2wQI</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Wei, Junhua</creator><creator>Qi, Xuchen</creator><creator>Zhan, Qitao</creator><creator>Zhou, Daoyang</creator><creator>Yan, Qingfeng</creator><creator>Wang, Yirong</creator><creator>Mo, Lianjie</creator><creator>Wan, Yingfeng</creator><creator>Xie, Dajiang</creator><creator>Xie, Jixi</creator><creator>Yang, Shuxu</creator><general>Elsevier Masson SAS</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201612</creationdate><title>Corrigendum to: “miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression” [Biomedicine &amp; Pharmacotherapy (71), (2015) 112–118]</title><author>Wei, Junhua ; Qi, Xuchen ; Zhan, Qitao ; Zhou, Daoyang ; Yan, Qingfeng ; Wang, Yirong ; Mo, Lianjie ; Wan, Yingfeng ; Xie, Dajiang ; Xie, Jixi ; Yang, Shuxu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2118-4eb3f67b592d97ac9f4c55caa8ddc15cf288e13716d843a529e56be4830fd64c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Internal Medicine</topic><topic>Medical Education</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wei, Junhua</creatorcontrib><creatorcontrib>Qi, Xuchen</creatorcontrib><creatorcontrib>Zhan, Qitao</creatorcontrib><creatorcontrib>Zhou, Daoyang</creatorcontrib><creatorcontrib>Yan, Qingfeng</creatorcontrib><creatorcontrib>Wang, Yirong</creatorcontrib><creatorcontrib>Mo, Lianjie</creatorcontrib><creatorcontrib>Wan, Yingfeng</creatorcontrib><creatorcontrib>Xie, Dajiang</creatorcontrib><creatorcontrib>Xie, Jixi</creatorcontrib><creatorcontrib>Yang, Shuxu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine &amp; pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wei, Junhua</au><au>Qi, Xuchen</au><au>Zhan, Qitao</au><au>Zhou, Daoyang</au><au>Yan, Qingfeng</au><au>Wang, Yirong</au><au>Mo, Lianjie</au><au>Wan, Yingfeng</au><au>Xie, Dajiang</au><au>Xie, Jixi</au><au>Yang, Shuxu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corrigendum to: “miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression” [Biomedicine &amp; Pharmacotherapy (71), (2015) 112–118]</atitle><jtitle>Biomedicine &amp; pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2016-12</date><risdate>2016</risdate><volume>84</volume><spage>1440</spage><epage>1441</epage><pages>1440-1441</pages><issn>0753-3322</issn><eissn>1950-6007</eissn><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>27769588</pmid><doi>10.1016/j.biopha.2016.09.109</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0753-3322
ispartof Biomedicine & pharmacotherapy, 2016-12, Vol.84, p.1440-1441
issn 0753-3322
1950-6007
language eng
recordid cdi_proquest_miscellaneous_1835517525
source Elsevier ScienceDirect Journals
subjects Internal Medicine
Medical Education
title Corrigendum to: “miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression” [Biomedicine & Pharmacotherapy (71), (2015) 112–118]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T07%3A21%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corrigendum%20to:%20%E2%80%9CmiR-20a%20mediates%20temozolomide-resistance%20in%20glioblastoma%20cells%20via%20negatively%20regulating%20LRIG1%20expression%E2%80%9D%20%5BBiomedicine%20&%20Pharmacotherapy%20(71),%20(2015)%20112%E2%80%93118%5D&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Wei,%20Junhua&rft.date=2016-12&rft.volume=84&rft.spage=1440&rft.epage=1441&rft.pages=1440-1441&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2016.09.109&rft_dat=%3Cproquest_cross%3E1835517525%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835517525&rft_id=info:pmid/27769588&rft_els_id=1_s2_0_S0753332216318029&rfr_iscdi=true